FCMI

Foresite Capital Management III Portfolio holdings

AUM $37.9M
This Quarter Return
-26.19%
1 Year Return
-6.87%
3 Year Return
+443.49%
5 Year Return
+535.97%
10 Year Return
–
AUM
$62.8M
AUM Growth
+$62.8M
Cap. Flow
-$71M
Cap. Flow %
-113.01%
Top 10 Hldgs %
100%
Holding
13
New
3
Increased
2
Reduced
3
Closed
4

Top Buys

1
BPMC
Blueprint Medicines
BPMC
$9.94M
2
MYOK
MyoKardia, Inc. Common Stock
MYOK
$2.76M
3
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$2.12M
4
FGEN icon
FibroGen
FGEN
$1.39M
5
EPZM
Epizyme, Inc
EPZM
$409K

Top Sells

1
AERI
Aerie Pharmaceuticals, Inc.
AERI
$26.9M
2
XLRN
Acceleron Pharma Inc.
XLRN
$19.1M
3
IMMU
Immunomedics Inc
IMMU
$18.2M
4
BOLD
Audentes Therapeutics, Inc
BOLD
$13.9M
5
REPL icon
Replimune Group
REPL
$4.51M

Sector Composition

1 Healthcare 83.75%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
MYOK
1
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$18.1M 28.77%
385,452
+58,970
+18% +$2.76M
EPZM
2
DELISTED
Epizyme, Inc
EPZM
$11.1M 17.63%
713,812
+26,385
+4% +$409K
BPMC
3
DELISTED
Blueprint Medicines
BPMC
$9.94M 15.82%
+169,900
New +$9.94M
NTRA icon
4
Natera
NTRA
$23.1B
$6.23M 9.93%
208,768
– –
IMMU
5
DELISTED
Immunomedics Inc
IMMU
$5.39M 8.59%
400,000
-1,350,000
-77% -$18.2M
AERI
6
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
$4.81M 7.66%
356,492
-1,993,985
-85% -$26.9M
XLRN
7
DELISTED
Acceleron Pharma Inc.
XLRN
$3.78M 6.01%
42,030
-212,893
-84% -$19.1M
BHVN
8
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$2.12M 3.37%
+62,245
New +$2.12M
FGEN icon
9
FibroGen
FGEN
$48.1M
$1.39M 2.21%
+40,000
New +$1.39M
ASND icon
10
Ascendis Pharma
ASND
$12.1B
– –
-13,922
Closed -$1.94M
REPL icon
11
Replimune Group
REPL
$456M
– –
-313,922
Closed -$4.51M
CBAY
12
DELISTED
Cymabay Therapeutics
CBAY
– –
-1,504,710
Closed -$2.95M
BOLD
13
DELISTED
Audentes Therapeutics, Inc
BOLD
– –
-233,067
Closed -$13.9M